Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
92,127,969
-
Share change
-
+4,762,784
-
Total reported value
-
$11,704,641,437
-
Put/Call ratio
-
78%
-
Price per share
-
$127.05
-
Number of holders
-
275
-
Value change
-
+$613,133,919
-
Number of buys
-
167
-
Number of sells
-
91
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q4 2017
As of 31 Dec 2017,
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) was held by
275 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
92,127,969 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, DODGE & COX, Vanguard Group Inc, BlackRock Inc., BAILLIE GIFFORD & CO, STATE STREET CORP, UBS ASSET MANAGEMENT AMERICAS INC, and Blue Ridge Capital, L.L.C..
This page lists
275
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.